NsG-0202

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNsG-0202
Drug Alias NameECB-ADECT-ADECT-NGFNsG-0202
ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionBeta-nerve growth factor stimulants
TargetsBeta-nerve growth factor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNsgene As
China Registration ClassN/A

Develop Information

Active CompaniesNsgene As
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A